ElevateBio CEO on disruptive potential for gene and cell therapies

David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.

May 15, 2024 - 23:18

0 2

ElevateBio CEO on disruptive potential for gene and cell therapies

David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.

Tags:

Previous Article

Stanley Black & Decker CEO Donald Allan Jr. goes one-on-one with Jim Cramer

Alphabet CEO on report OpenAI trained GPT-4 on YouTube: We have clear terms of s...

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.